Descriptions

G-type lectin S-receptor-like serine/threonine-protein kinase At1g61550 (At1g61550) is annotated based on its experimentally validated activation loop, which is expected to act as accessory element in the autoinhibition of At1g61550.

Autoinhibitory domains (AIDs)

Target domain

165-303 (Domain II)

Relief mechanism

Partner binding, PTM

Assay

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q61526

Entry ID Method Resolution Chain Position Source
AF-Q61526-F1 Predicted AlphaFoldDB

76 variants for Q61526

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3389136583 16 L>M No EVA
rs3389141859 28 V>I No EVA
rs3389075131 136 F>L No EVA
rs3389110933 141 E>K No EVA
rs3389133933 151 K>M No EVA
rs241833984 182 N>S No EVA
rs3389137725 200 E>K No EVA
rs3389122525 203 Q>H No EVA
rs3389075160 214 C>Y No EVA
rs3389137747 220 G>R No EVA
rs3389131181 229 D>Y No EVA
rs3389135177 281 Q>H No EVA
rs3401776874 307 A>S No EVA
rs3401783110 310 M>L No EVA
rs3389129400 350 G>V No EVA
rs3389583791 383 K>R No EVA
rs3389146613 428 F>L No EVA
rs3389135220 458 A>V No EVA
rs3389075185 463 C>S No EVA
rs3389131119 466 H>D No EVA
rs3401137872 473 L>P No EVA
rs237692324 478 A>V No EVA
rs3389129471 499 V>A No EVA
rs3389075155 509 C>F No EVA
rs3389129468 520 C>R No EVA
rs31482901 574 A>T No EVA
rs3389122440 577 A>D No EVA
rs3389135022 578 H>P No EVA
rs3389137548 578 H>Q No EVA
rs3389099314 615 E>D No EVA
rs223957013 651 T>A No EVA
rs3389146621 658 G>* No EVA
rs3389141886 658 G>* No EVA
rs3389108006 659 G>V No EVA
rs3389146629 660 S>A No EVA
rs1134105105 668 R>K No EVA
rs3389122471 680 E>K No EVA
rs3389134972 695 N>K No EVA
rs3389141882 695 N>T No EVA
rs3389141870 703 K>* No EVA
rs3389075101 738 C>R No EVA
rs3389110969 739 I>N No EVA
rs3389075121 755 T>S No EVA
rs3389099282 785 T>I No EVA
rs246059432 786 Q>H No EVA
rs3389129463 795 D>E No EVA
rs3389131159 813 G>R No EVA
rs3389075136 820 M>R No EVA
rs3389135186 851 F>C No EVA
rs3389129439 870 K>E No EVA
rs3389146632 887 T>A No EVA
rs3389134977 896 G>D No EVA
rs3389129412 923 E>G No EVA
rs3389111018 955 T>S No EVA
rs3389145706 964 T>P No EVA
rs3389108026 989 E>A No EVA
rs228576632 1039 R>H No EVA
rs3389099284 1058 N>I No EVA
rs252662865 1067 A>V No EVA
rs3401137895 1072 R>L No EVA
rs3389141869 1078 P>S No EVA
rs3389135224 1100 G>C No EVA
rs3389107970 1104 E>K No EVA
rs3389131174 1109 V>L No EVA
rs3389141843 1111 M>I No EVA
rs3389110977 1188 E>K No EVA
rs261256216 1189 D>E No EVA
rs3389131184 1199 R>E* No EVA
rs3389129458 1200 K>R No EVA
rs3389135229 1201 R>S No EVA
rs3389137666 1266 A>G No EVA
rs3389137545 1297 H>L No EVA
rs3389137689 1297 H>N No EVA
rs3389129410 1298 Q>* No EVA
rs3389099350 1324 D>G No EVA
rs3401776854 1340 I>S No EVA

No associated diseases with Q61526

13 regional properties for Q61526

Type Name Position InterPro Accession
domain C2 domain 1 - 118 IPR000008
domain Protein kinase domain 355 - 614 IPR000719
domain AGC-kinase, C-terminal 615 - 683 IPR000961
domain Protein kinase C-like, phorbol ester/diacylglycerol-binding domain 171 - 225 IPR002219-1
domain Protein kinase C-like, phorbol ester/diacylglycerol-binding domain 245 - 297 IPR002219-2
active_site Serine/threonine-protein kinase, active site 475 - 487 IPR008271
binding_site Protein kinase, ATP binding site 361 - 384 IPR017441
domain Protein kinase, C-terminal 635 - 676 IPR017892
domain Diacylglycerol/phorbol-ester binding 169 - 183 IPR020454-1
domain Diacylglycerol/phorbol-ester binding 185 - 194 IPR020454-2
domain Diacylglycerol/phorbol-ester binding 199 - 210 IPR020454-3
domain Diacylglycerol/phorbol-ester binding 284 - 296 IPR020454-4
domain Novel protein kinase C eta, catalytic domain 359 - 681 IPR034665

Functions

Description
EC Number 2.7.11.1 Protein-serine/threonine kinases
Subcellular Localization
  • Cell membrane ; Single-pass type I membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

9 GO annotations of cellular component

Name Definition
apical plasma membrane The region of the plasma membrane located at the apical end of the cell.
basal plasma membrane The region of the plasma membrane located at the basal end of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis.
basolateral plasma membrane The region of the plasma membrane that includes the basal end and sides of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis.
ERBB3:ERBB2 complex A heterodimeric complex between the tyrosine kinase receptor ERBB2 and a ligand-activated receptor ERBB3. ERBB2, which does not bind any known ligand, is activated through formation of a heterodimer with another ligand-activated ERBB family member such as ERBB3.
extracellular space That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
lateral plasma membrane The portion of the plasma membrane at the lateral side of the cell. In epithelial cells, lateral plasma membranes are on the sides of cells which lie at the interface of adjacent cells.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
postsynaptic membrane A specialized area of membrane facing the presynaptic membrane on the tip of the nerve ending and separated from it by a minute cleft (the synaptic cleft). Neurotransmitters cross the synaptic cleft and transmit the signal to the postsynaptic membrane.
receptor complex Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.

11 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
ErbB-3 class receptor binding Binding to the protein-tyrosine kinase receptor ErbB-3/HER3.
identical protein binding Binding to an identical protein or proteins.
neuregulin binding Binding to a neuregulin, a member of the EGF family of growth factors.
neuregulin receptor activity Combining with a neuregulin, a member of the EGF family of growth factors, and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
protein heterodimerization activity Binding to a nonidentical protein to form a heterodimer.
protein kinase activity Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction
protein tyrosine kinase activator activity Increases the activity of a protein tyrosine kinase, an enzyme which phosphorylates a tyrosyl phenolic group on a protein.
signaling receptor activity Receiving a signal and transmitting it in the cell to initiate a change in cell activity. A signal is a physical entity or change in state that is used to transfer information in order to trigger a response.
transmembrane signaling receptor activity Combining with an extracellular or intracellular signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity or state as part of signal transduction.
ubiquitin protein ligase binding Binding to a ubiquitin protein ligase enzyme, any of the E3 proteins.

26 GO annotations of biological process

Name Definition
cranial nerve development The process whose specific outcome is the progression of the cranial nerves over time, from its formation to the mature structure. The cranial nerves are composed of twelve pairs of nerves that emanate from the nervous tissue of the hindbrain. These nerves are sensory, motor, or mixed in nature, and provide the motor and general sensory innervation of the head, neck and viscera. They mediate vision, hearing, olfaction and taste and carry the parasympathetic innervation of the autonomic ganglia that control visceral functions.
endocardial cushion development The progression of a cardiac cushion over time, from its initial formation to the mature structure. The endocardial cushion is a specialized region of mesenchymal cells that will give rise to the heart septa and valves.
epidermal growth factor receptor signaling pathway The series of molecular signals initiated by binding of a ligand to the tyrosine kinase receptor EGFR (ERBB1) on the surface of a cell. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
ERBB2-ERBB3 signaling pathway The series of molecular signals initiated by binding of a ligand to a ERBB3 receptor on the surface of a cell, followed by transmission of the signal by a heterodimeric complex of ERBB2 and ERBB3. ERBB2, which does not bind any known ligand, is activated through formation of a heterodimer with another ligand-activated ERBB family member such as ERBB3. ERBB3 also has impaired kinase activity and relies on ERBB2 for activation and signal transmission.
extrinsic apoptotic signaling pathway in absence of ligand The series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with withdrawal of a ligand from a cell surface receptor, and ends when the execution phase of apoptosis is triggered.
motor neuron apoptotic process Any apoptotic process in a motor neuron, an efferent neuron that passes from the central nervous system or a ganglion toward or to a muscle and conducts an impulse that causes movement.
myelination The process in which myelin sheaths are formed and maintained around neurons. Oligodendrocytes in the brain and spinal cord and Schwann cells in the peripheral nervous system wrap axons with compact layers of their plasma membrane. Adjacent myelin segments are separated by a non-myelinated stretch of axon called a node of Ranvier.
negative regulation of apoptotic process Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
negative regulation of cell adhesion Any process that stops, prevents, or reduces the frequency, rate or extent of cell adhesion.
negative regulation of motor neuron apoptotic process Any process that stops, prevents or reduces the frequency, rate or extent of motor neuron apoptotic process.
negative regulation of neuron apoptotic process Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons.
negative regulation of secretion Any process that stops, prevents, or reduces the frequency, rate or extent of the controlled release of a substance from a cell or a tissue.
negative regulation of signal transduction Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction.
neurogenesis Generation of cells within the nervous system.
neuron apoptotic process Any apoptotic process in a neuron, the basic cellular unit of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the nervous system.
peripheral nervous system development The process whose specific outcome is the progression of the peripheral nervous system over time, from its formation to the mature structure. The peripheral nervous system is one of the two major divisions of the nervous system. Nerves in the PNS connect the central nervous system (CNS) with sensory organs, other organs, muscles, blood vessels and glands.
phosphatidylinositol 3-kinase/protein kinase B signal transduction A series of reactions, mediated by the intracellular serine/threonine kinase protein kinase B (also called AKT), which occurs as a result of a single trigger reaction or compound.
phosphorylation The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.
positive regulation of calcineurin-NFAT signaling cascade Any process that activates or increases the frequency, rate or extent of signaling via the calcineurin-NFAT signaling cascade.
positive regulation of cardiac muscle tissue development Any process that activates, maintains or increases the frequency, rate or extent of cardiac muscle tissue development.
positive regulation of cell population proliferation Any process that activates or increases the rate or extent of cell proliferation.
positive regulation of gene expression Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA).
positive regulation of glucose import Any process that activates or increases the frequency, rate or extent of the import of the hexose monosaccharide glucose into a cell or organelle.
Schwann cell development The process aimed at the progression of a Schwann cell over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell. Schwann cells are found in the peripheral nervous system, where they insulate neurons and axons, and regulate the environment in which neurons function.
Schwann cell differentiation The process in which a relatively unspecialized cell acquires the specialized features of a Schwann cell. Schwann cells are found in the peripheral nervous system, where they insulate neurons and axons, and regulate the environment in which neurons function.
transmembrane receptor protein tyrosine kinase signaling pathway The series of molecular signals initiated by an extracellular ligand binding to a receptor on the surface of the target cell where the receptor possesses tyrosine kinase activity, and ending with the regulation of a downstream cellular process, e.g. transcription.

54 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P13387 EGFR Epidermal growth factor receptor Gallus gallus (Chicken) SS
P00533 EGFR Epidermal growth factor receptor Homo sapiens (Human) EV
P04626 ERBB2 Receptor tyrosine-protein kinase erbB-2 Homo sapiens (Human) SS
Q15303 ERBB4 Receptor tyrosine-protein kinase erbB-4 Homo sapiens (Human) SS
P21860 ERBB3 Receptor tyrosine-protein kinase erbB-3 Homo sapiens (Human) SS
P70424 Erbb2 Receptor tyrosine-protein kinase erbB-2 Mus musculus (Mouse) SS
Q01279 Egfr Epidermal growth factor receptor Mus musculus (Mouse) SS
Q01887 Ryk Tyrosine-protein kinase RYK Mus musculus (Mouse) PR
P35546 Ret Proto-oncogene tyrosine-protein kinase receptor Ret Mus musculus (Mouse) SS
Q61006 Musk Muscle, skeletal receptor tyrosine-protein kinase Mus musculus (Mouse) SS
Q9Z138 Ror2 Tyrosine-protein kinase transmembrane receptor ROR2 Mus musculus (Mouse) SS
Q9Z139 Ror1 Inactive tyrosine-protein kinase transmembrane receptor ROR1 Mus musculus (Mouse) PR
Q62371 Ddr2 Discoidin domain-containing receptor 2 Mus musculus (Mouse) SS
Q03146 Ddr1 Epithelial discoidin domain-containing receptor 1 Mus musculus (Mouse) SS
P15209 Ntrk2 BDNF/NT-3 growth factors receptor Mus musculus (Mouse) SS
Q3UFB7 Ntrk1 High affinity nerve growth factor receptor Mus musculus (Mouse) SS
Q6VNS1 Ntrk3 NT-3 growth factor receptor Mus musculus (Mouse) SS
P35917 Flt4 Vascular endothelial growth factor receptor 3 Mus musculus (Mouse) SS
P35969 Flt1 Vascular endothelial growth factor receptor 1 Mus musculus (Mouse) SS
P35918 Kdr Vascular endothelial growth factor receptor 2 Mus musculus (Mouse) PR
Q03145 Epha2 Ephrin type-A receptor 2 Mus musculus (Mouse) PR
Q60750 Epha1 Ephrin type-A receptor 1 Mus musculus (Mouse) SS
P54761 Ephb4 Ephrin type-B receptor 4 Mus musculus (Mouse) PR
Q60629 Epha5 Ephrin type-A receptor 5 Mus musculus (Mouse) SS
P97793 Alk ALK tyrosine kinase receptor Mus musculus (Mouse) SS
Q9WTL4 Insrr Insulin receptor-related protein Mus musculus (Mouse) SS
Q60751 Igf1r Insulin-like growth factor 1 receptor Mus musculus (Mouse) SS
P15208 Insr Insulin receptor Mus musculus (Mouse) SS
P16092 Fgfr1 Fibroblast growth factor receptor 1 Mus musculus (Mouse) SS
P21803 Fgfr2 Fibroblast growth factor receptor 2 Mus musculus (Mouse) SS
Q03142 Fgfr4 Fibroblast growth factor receptor 4 Mus musculus (Mouse) PR
Q60805 Mertk Tyrosine-protein kinase Mer Mus musculus (Mouse) SS
Q62190 Mst1r Macrophage-stimulating protein receptor Mus musculus (Mouse) SS
Q00993 Axl Tyrosine-protein kinase receptor UFO Mus musculus (Mouse) PR
P55144 Tyro3 Tyrosine-protein kinase receptor TYRO3 Mus musculus (Mouse) SS
Q61527 Erbb4 Receptor tyrosine-protein kinase erbB-4 Mus musculus (Mouse) SS
Q02858 Tek Angiopoietin-1 receptor Mus musculus (Mouse) SS
Q06806 Tie1 Tyrosine-protein kinase receptor Tie-1 Mus musculus (Mouse) SS
P05532 Kit Mast/stem cell growth factor receptor Kit Mus musculus (Mouse) PR
P05622 Pdgfrb Platelet-derived growth factor receptor beta Mus musculus (Mouse) SS
P09581 Csf1r Macrophage colony-stimulating factor 1 receptor Mus musculus (Mouse) SS
P26618 Pdgfra Platelet-derived growth factor receptor alpha Mus musculus (Mouse) SS
Q00342 Flt3 Receptor-type tyrosine-protein kinase FLT3 Mus musculus (Mouse) SS
Q61851 Fgfr3 Fibroblast growth factor receptor 3 Mus musculus (Mouse) PR
P16056 Met Hepatocyte growth factor receptor Mus musculus (Mouse) PR
Q62956 Erbb4 Receptor tyrosine-protein kinase erbB-4 Rattus norvegicus (Rat) SS
P06494 Erbb2 Receptor tyrosine-protein kinase erbB-2 Rattus norvegicus (Rat) SS
Q62799 Erbb3 Receptor tyrosine-protein kinase erbB-3 Rattus norvegicus (Rat) SS
P55245 EGFR Epidermal growth factor receptor Macaca mulatta (Rhesus macaque) SS
O16262 nipi-4 Protein nipi-4 Caenorhabditis elegans PR
Q9LMN7 WAK5 Wall-associated receptor kinase 5 Arabidopsis thaliana (Mouse-ear cress) PR
Q9LSV3 WAKL16 Putative wall-associated receptor kinase-like 16 Arabidopsis thaliana (Mouse-ear cress) PR
Q9M342 WAKL15 Wall-associated receptor kinase-like 15 Arabidopsis thaliana (Mouse-ear cress) PR
Q8VZJ9 CRCK2 Calmodulin-binding receptor-like cytoplasmic kinase 2 Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MTRFACFLFS TLLLSFSYAA ITPTSPLSIG QTLSSPNGIF ELGFFSPNNS RNLYVGIWFK
70 80 90 100 110 120
GIIPRTVVWV ANRENSVTDA TADLAISSNG SLLLFDGKHS TVWSTGETFA SNGSSAELSD
130 140 150 160 170 180
SGNLLVIDKV SGITLWQSFE HLGDTMLPYS SLMYNPGTGE KRVLSSWKSY TDPLPGEFVG
190 200 210 220 230 240
YITTQVPPQG FIMRGSKPYW RSGPWAKTRF TGVPLTDESY THPFSVQQDA NGSVYFSHLQ
250 260 270 280 290 300
RNFKRSLLVL TSEGSLKVTH HNGTDWVLNI DVPANTCDFY GVCGPFGLCV MSIPPKCKCF
310 320 330 340 350 360
KGFVPQFSEE WKRGNWTGGC VRRTELLCQG NSTGRHVNVF HPVANIKPPD FYEFVSSGSA
370 380 390 400 410 420
EECYQSCLHN CSCLAFAYIN GIGCLIWNQE LMDVMQFSVG GELLSIRLAS SEMGGNQRKK
430 440 450 460 470 480
TIIASIVSIS LFVTLASAAF GFWRYRLKHN AIVSKVSLQG AWRNDLKSED VSGLYFFEMK
490 500 510 520 530 540
TIEIATNNFS LVNKLGQGGF GPVYKGKLQD GKEIAVKRLS SSSGQGKEEF MNEILLISKL
550 560 570 580 590 600
QHINLVRILG CCIEGEERLL VYEFMVNKSL DTFIFDSRKR VEIDWPKRFS IIQGIARGLL
610 620 630 640 650 660
YLHRDSRLRI IHRDVKVSNI LLDDKMNPKI SDFGLARMYE GTKYQDNTRR IVGTLGYMSP
670 680 690 700 710 720
EYAWTGVFSE KSDTYSFGVL LLEVISGEKI SRFSYDKERK NLLAYAWESW CENGGVGFLD
730 740 750 760 770 780
KDATDSCHPS EVGRCVQIGL LCVQHQPADR PNTLELLSML TTTSDLPLPK EPTFAVHTSD
790 800
DGSRTSDLIT VNEVTQSVVL GR